Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 36.00
+1.25 (3.60%)
Sep 8, 2026, 12:20 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.84 billion as of September 4, 2026. Its market cap has increased by 16.22% in one year.
Market Cap
4.84B
Enterprise Value
7.04B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
ChartMarket Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.84B, an increase of 607.15%. That is a compound annual growth rate of 9.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 4.84B | 7.25% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.35B |
| TaiGen Biopharmaceuticals Holdings | 6.23B |
| Sinphar Pharmaceutical | 6.17B |
| Steminent Biotherapeutics | 6.16B |
| AnnJi Pharmaceutical | 5.82B |
| Mycenax Biotech | 4.96B |
| UnicoCell Biomed | 4.69B |
| Pharmosa Biopharm | 4.28B |